Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02CCA
|
||||
Former ID |
DIB006564
|
||||
Drug Name |
GSK-172981
|
||||
Synonyms |
GSK-172981; GSK-256471; SB-218795; SB-235375; SB-244487; SB-400238; SB-414240; SK-797230; NK-2 antagonists, GSK; NK-3 antagonists, GlaxoSmithKline; NK-3 antagonists, SB
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Asthma [ICD10:J45] | Investigative | [541097] | ||
Company |
SmithKline Beecham SpA
|
||||
Structure |
Download2D MOL |
||||
Formula |
C29H29N3O3S
|
||||
InChI |
InChI=1S/C29H29N3O3S/c1-32(36(2,34)35)19-24-26(29(33)31-27(22-17-18-22)20-11-5-3-6-12-20)23-15-9-10-16-25(23)30-28(24)21-13-7-4-8-14-21/h3-16,22,27H,17-19H2,1-2H3,(H,31,33)/t27-/m1/s1
|
||||
InChIKey |
YTXUTYGRBYCUIL-HHHXNRCGSA-N
|
||||
CAS Number |
CAS 174635-53-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Nigral tachykinin NK(3) receptor | Target Info | Antagonist | [543793] | |
Reactome | G alpha (q) signalling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.